T. Rowe Price Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
105,762
+7,156
| +7% | +$80.6K | ﹤0.01% | 1902 |
|
|
2025
Q1 | $934K | Sell |
98,606
-645,839
| -87% | -$6.12M | ﹤0.01% | 1991 |
|
|
2024
Q4 | $8.38M | Buy |
744,445
+28,540
| +4% | +$321K | ﹤0.01% | 1175 |
|
|
2024
Q3 | $20.2M | Sell |
715,905
-7,054
| -1% | -$199K | ﹤0.01% | 989 |
|
|
2024
Q2 | $13.8M | Buy |
722,959
+5,625
| +0.8% | +$108K | ﹤0.01% | 1043 |
|
|
2024
Q1 | $23.5M | Buy |
717,334
+75,376
| +12% | +$2.47M | ﹤0.01% | 939 |
|
|
2023
Q4 | $21.2M | Buy |
641,958
+4,080
| +0.6% | +$135K | ﹤0.01% | 939 |
|
|
2023
Q3 | $17.4M | Sell |
637,878
-212,383
| -25% | -$5.78M | ﹤0.01% | 948 |
|
|
2023
Q2 | $25.8M | Buy |
850,261
+6,317
| +0.7% | +$191K | ﹤0.01% | 867 |
|
|
2023
Q1 | $27.4M | Sell |
843,944
-3,185
| -0.4% | -$103K | ﹤0.01% | 840 |
|
|
2022
Q4 | $23.8M | Buy |
847,129
+94,043
| +12% | +$2.64M | ﹤0.01% | 863 |
|
|
2022
Q3 | $27.1M | Buy |
753,086
+715,327
| +1,894% | +$25.7M | ﹤0.01% | 821 |
|
|
2022
Q2 | $1.16M | Buy |
37,759
+3,382
| +10% | +$104K | ﹤0.01% | 1821 |
|
|
2022
Q1 | $1.11M | Buy |
34,377
+4,340
| +14% | +$140K | ﹤0.01% | 1946 |
|
|
2021
Q4 | $831K | Sell |
30,037
-5,035
| -14% | -$139K | ﹤0.01% | 2117 |
|
|
2021
Q3 | $1.09M | Sell |
35,072
-1,500
| -4% | -$46.5K | ﹤0.01% | 2019 |
|
|
2021
Q2 | $772K | Sell |
36,572
-661
| -2% | -$14K | ﹤0.01% | 2171 |
|
|
2021
Q1 | $752K | Sell |
37,233
-3,971
| -10% | -$80.2K | ﹤0.01% | 2178 |
|
|
2020
Q4 | $661K | Buy |
41,204
+7,900
| +24% | +$127K | ﹤0.01% | 2115 |
|
|
2020
Q3 | $413K | Sell |
33,304
-19,100
| -36% | -$237K | ﹤0.01% | 2167 |
|
|
2020
Q2 | $373K | Sell |
52,404
-4,438
| -8% | -$31.6K | ﹤0.01% | 2174 |
|
|
2020
Q1 | $309K | Buy |
56,842
+787
| +1% | +$4.28K | ﹤0.01% | 2178 |
|
|
2019
Q4 | $507K | Buy |
56,055
+36,482
| +186% | +$330K | ﹤0.01% | 2141 |
|
|
2019
Q3 | $141K | Buy |
19,573
+362
| +2% | +$2.61K | ﹤0.01% | 2414 |
|
|
2019
Q2 | $153K | Buy |
19,211
+310
| +2% | +$2.47K | ﹤0.01% | 2430 |
|
|
2019
Q1 | $238K | Buy |
18,901
+200
| +1% | +$2.52K | ﹤0.01% | 2358 |
|
|
2018
Q4 | $373K | Buy |
18,701
+328
| +2% | +$6.54K | ﹤0.01% | 2187 |
|
|
2018
Q3 | $522K | Buy |
18,373
+597
| +3% | +$17K | ﹤0.01% | 2129 |
|
|
2018
Q2 | $374K | Sell |
17,776
-5,077
| -22% | -$107K | ﹤0.01% | 2258 |
|
|
2018
Q1 | $326K | Buy |
22,853
+285
| +1% | +$4.07K | ﹤0.01% | 2250 |
|
|
2017
Q4 | $278K | Buy |
22,568
+6,760
| +43% | +$83.3K | ﹤0.01% | 2291 |
|
|
2017
Q3 | $281K | Buy |
15,808
+100
| +0.6% | +$1.78K | ﹤0.01% | 2285 |
|
|
2017
Q2 | $398K | Sell |
15,708
-936
| -6% | -$23.7K | ﹤0.01% | 2143 |
|
|
2017
Q1 | $371K | Buy |
16,644
+13
| +0.1% | +$290 | ﹤0.01% | 2168 |
|
|
2016
Q4 | $246K | Buy |
+16,631
| New | +$246K | ﹤0.01% | 2313 |
|